Astrana Health (ASTH) vs ICF International (ICFI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Astrana Health (ASTH) has outperformed ICF International (ICFI) over the past year, gaining 22.5% versus a loss of 10.4%. Over five years, ICFI leads with a -15.5% price change compared with -48.0% for ASTH. Astrana Health is the larger company by market cap ($1.84 billion vs $1.49 billion), about 1.2 times the size.
On valuation, Astrana Health trades at a lower forward P/E (10.2x vs 10.7x for ICF International). ICF International pays a dividend yielding 0.68%, while Astrana Health does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASTH | ICFI |
|---|---|---|
| Share price | $37.14 | $82.85 |
| Market cap | $1.84B | $1.49B |
| 1-day change | +0.38% | -0.29% |
| YTD return | +49.70% | -2.87% |
| 1-year return | +22.45% | -10.38% |
| 5-year return | -48.05% | -15.49% |
| P/E ratio (TTM) | 44.75 | 17.15 |
| Forward P/E | 10.21 | 10.75 |
| EPS (TTM) | $0.83 | $4.83 |
| Dividend yield | 0.00% | 0.68% |
| Annual dividend | $0.00 | $0.56 |
| 52-week high | $51.60 | $98.03 |
| 52-week low | $18.08 | $58.83 |
| Distance from 52-week high | -28.02% | -15.49% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +39.12% | +29.45% |
| Average volume | 462.64K | 204.25K |
| Shares outstanding | 49.60M | 17.93M |
| Employees | 3,000 | 6,972 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Professional Services | Professional Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ASTH has outperformed ICFI by 32.8 percentage points over the past year.
- Astrana Health trades at a higher earnings multiple (44.7x vs 17.2x trailing P/E).
About Astrana Health
ASTH stock →Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.
Consumer Discretionary · Professional Services · 3,000 employees
About ICF International
ICFI stock →ICF International, Inc. provides management, technology, and policy consulting and implementation services to government and commercial clients in the United States and internationally.
Consumer Discretionary · Professional Services · 6,972 employees
ASTH vs ICFI FAQ
Which is bigger, Astrana Health or ICF International?
Astrana Health (ASTH) is larger, with a market capitalization of $1.84B compared with $1.49B for ICF International (ICFI).
Which stock has performed better over the past year, ASTH or ICFI?
ASTH returned +22.45% over the past 12 months, compared with -10.38% for ICFI (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ASTH or ICFI?
ICFI has the lower trailing P/E at 17.2, versus 44.7 for ASTH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Astrana Health or ICF International?
ICF International pays a dividend yielding 0.68%, while Astrana Health does not currently pay a regular dividend.
Are Astrana Health and ICF International in the same industry?
Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.